the adc therapeutics ( dbc ) market is a rapidly evolving area of research and research. the dbc market is a fast moving space with new treatment paradigms approved or near approval. in addition, the dbc market is highly fragmented and is highly fragmented. we believe that the market is a fast moving space with new treatments paradigms approved or near approval. we believe that the market is characterized by a tremendous gap in the market and that we will be well positioned for growth in potential combinations and in earlier lines of therapy. we believe that we have a clear road map and the capabilities to execute on our new strategy to help create future value for all of our stakeholders.